EXG001-307

N/A

Report date: 2023/10/26 17:02:31

Base Information

Drug NameEXG001-307

Drug Alias NameEXG001-307

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV9 vector

Mechanisms of ActionSMN gene transference

TargetsSurvival motor neuron protein

Therapy Area/IndicationsMuscular Atrophy, Spinal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesExegenesis Bio Inc

China Registration ClassClass 1 therapeutic biologic in China

Inactive CompaniesN/A

Active IndicationsMuscular Atrophy, Spinal

Inactive IndicationsN/A

ATC CodeN/A